A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms
A phase 3 trial of Peginterferon alfa-2b and Hydroxyurea in Polycythaemia vera, Essential thrombocythaemia and Primary myelofibrosis, run by Thomas Stauffer Larsen, completed.
Overview
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms is a phase 3 interventional study registered as NCT01387763 by Thomas Stauffer Larsen, with 202 participants recorded, started 2012-01 and reaching its primary completion in 2020-06. Interventions recorded: PegIntron, Pegasys, PegIntron, Pegasys, Hydrea. Conditions recorded: Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis.
Linked to the drug Peginterferon alfa-2b because the registry names it among its interventions and Polycythaemia vera, Essential thrombocythaemia and Primary myelofibrosis among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialExtension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Shares Essential thrombocythaemia (ET), Polycythaemia vera (PV) and the tag pipeline.
- TrialPhase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Shares Peginterferon alfa-2b and the tag pipeline.
- TreatmentBomedemstat
Shares Essential thrombocythaemia (ET), Polycythaemia vera (PV) and the tag pipeline.
- TrialINTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Shares Polycythaemia vera (PV) and the tag pipeline.
- TrialExtended Access of Momelotinib in Adults With Myelofibrosis
Shares Primary myelofibrosis and the tag pipeline.
- TrialA Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Shares Polycythaemia vera (PV) and the tag pipeline.
- TrialFostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
Shares Primary myelofibrosis and the tag pipeline.
- TrialA Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
Shares Essential thrombocythaemia (ET) and the tag pipeline.